Farmacia / Julio 2021



En la seleccion de artículos colaboro la Dra. Cristina Fernández Barrantes



American Journal of Health System Pharmacy 2021 78 (1)

1. Treatment of chronic hepatitis C virus infection with crushed ledipasvir/sofosbuvir administered through a percutaneous endoscopic gastrostomy tube in a patient with HIV coinfection. Pág. 36-40.
2. Development of an innovative delivery system for bacillus Calmette-Guérin bladder administration. Pág. 60-64.

American Journal of Health System Pharmacy 2021 78 (2)

3. Pharmacy-facilitated medication history program at a community teaching hospital: A pre-post study in an emergency department. Pág. 135-140.
4. Creation and maintenance of a table for assessment of evolving evidence for COVID-19–related treatments. Pág.154-157.
5. ASHP Guidelines on Medication-Use Evaluation. Pág. 168-175

American Journal of Health System Pharmacy 2021 78 (3)

6. Nifurtimox. Pág. 177-180.
7. Comparison of intermittent audit vs daily documentation of pharmacist interventions. Pág. 222-228.

American Journal of Health System Pharmacy 2021 78 (5)

8. To crush or not to crush: A brief review of novel tablets and capsules prepared from nanocrystal and amorphous solid dispersion technologies. Pág. 389-394.
9. Weight gain associated with insulin detemir vs insulin glargine in clinical practice: A retrospective longitudinal cohort study. Pág . 401-407.

American Journal of Health System Pharmacy 2021 78 (8)

10. Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination.Pág. 674-683.
11. Impact of hydroxychloroquine on disease progression and ICU admissions in patients with SARS-CoV-2 infection. Pág. 689-696.
12. Network meta-analysis of infliximab biosimilars for the treatment of rheumatoid arthritis. Pág.697-704.
13. Antimicrobial stewardship perspectives from a New York City hospital during the COVID-19 pandemic: Challenges and opportunities. Pág. 743-750.

American Journal of Health System Pharmacy 2021 78 (9)

14. Burnout and secondary traumatic stress in health-system pharmacists during the COVID-19 pandemic. Pág. 818-824.

American Journal of Healht System Pharmacy 2021 78 (10)

15. Guidance on the treatment of antipsychotic-induced hyperprolactinemia when switching the antipsychotic is not an option. Pág. 862-871.

Current Opinion in Pharmacology 2021 56

16. Prospects for COPD treatment .Pág. 74-84.

Current Opinion in Pharmacology 2021 57

17. Circadian clocks regulate cardiac arrhythmia susceptibility, repolarization, and ion channels. Pág 13-20.
18. Corticosteroids and circadian rhythms in the cardiovascular system. Pág. 41-48.
19. Circadian influence on inflammatory response during cardiovascular disease. Pág. 60-70.
20. Chronotherapy of cardiac and vascular disease: timing medications to circadian rhythms to optimize treatment effects and outcomes. Pág. 41-48.
21. Precision medicine in idiopathic pulmonary fibrosis therapy: From translational research to patient-centered care. Pág. 71-80.

Current Opinion in Pharmacology 2021 58

22. The potential role of oxytocin in addiction: What is the target process? .Pág. 8-20.
23. Testosterone therapy for prevention and reversal of type 2 diabetes in men with low testosterone. Pág. 83-89.

Clinical Obstetrics and Gynecology 2021 64 (2)

24. Background, Etiology, and Subtypes of Urinary In continence. Pág. 259-265.

Farmacia Hospitalaria 2021 45 (1)

25. Persistencia de secukinumab en pacientes con psoriasis, artritis psoriásica y espondilitis Anquilosante. Pág. 16-21.
26. Evaluar medicamentos también es una actividad clínica. Pág.45-47.
27. Metodología Lean: diseño y evaluación de un modelo estandarizado de almacenaje de medicación. Pág. 3-9.

Farmacia Hospitalaria 2021 45 (2)

28. Protocolo de profilaxis antibiótica preoperatoria para pacientes ortopédicos del Hospital México: un análisis de cumplimiento. Pág. 61-65.
29. Evaluación de la neutropenia secundaria a micofenolato de mofetilo asociado a valganciclovir en pacientes trasplantados hepáticos. Pág. 77-81.
30. Adaptación nacional de la herramienta Start Smart-Then Focus para la optimización del uso de antimicrobianos. Pág. 82-88.
31. Cómo ha impactado la COVID-19 a nivel mundial en el papel del farmacéutico. Pág. 89-95.
32. Monitorización de las superficies de trabajode medicamentos peligrosos en los Servicios de Farmacia. Documento de consenso.Guía de práctica farmacéutica de la Sociedad Española de Farmacia Hospitalaria (SEFH). Pág. 96-107.

Farmacia Hospitalaria 2021 45 (3)

33. Multicentric study on the incidence and preventability of medication-related incidents in patients visiting pediatric emergency departments. Pág. 115-120.
34. Guía de administración de antineoplásicos orales en pacientes con trastornos de la deglución. Pág. 126-134.
35. Reacciones adversas a radiofármacos. Pág. 142-149.

Journal of Clinical Pharmacology Therapeutics    2021 4(1)

36. Self-management among type 2 diabetes patients via the WeChat application: A systematic review and meta-analysis. Pág. 4-16.
37. Chloroquine and hydroxychloroquine for COVID-19: Perspectives on their failure in repurposing. Pág. 17-27.
38. Does fasting during Ramadan influence the therapeutic effect of warfarin? Pág.86-92.
39. Analysis of time course and dose effect of tacrolimus on proteinuria in lupus nephritis patients. Pág. 106-113.
40. Impact of pharmacist intervention for blood pressure control in patients with chronic kidney disease: A meta-analysis of randomized clinical trials. Pág. 114-120.
41. Clinical pharmacy interventions in intensive care unit patients. Pág. 128-133.
42. Low-density lipoprotein cholesterol reduction and target achievement after switching from statin monotherapy to statin/ezetimibe combination therapy: Real-world evidence. Pág. 134-142.
43. Impact of interventions targeting the inappropriate use of proton-pump inhibitors by clinical pharmacists in a hepatobiliary surgery department. Pág. 149-153.
44. Short-course versus long-course antibiotic treatment in patients with uncomplicated gram-negative bacteremia: A systematic review and meta-analysis. Pág. 173-180.

Journal of Clinical Pharmacology Therapeutics 2021 4(2)

45. The Zika virus: Lurking behind the COVID-19 pandemic? Pág. 267-275.
46. Utility of the respiratory viral panel as an antimicrobial stewardship tool. Pág. 277-285.
47. A retrospective test for a possible relationship between linezolid-induced thrombocytopenia and hyponatraemia, Pág. 343-351.
48. Development of a pharmacy ‘patient prioritization tool’ for use in a Tertiary Paediatric Hospital. Pág. 388-394.
49. Monitoring antimicrobial cross-resistance with cross-resistance rate correlation diagrams: Changes in antibiotic susceptibility of Pseudomonas aeruginosa due to hospital relocation. Pág.395-407.
50. Association of prior fluoroquinolone treatment with survival outcomes of immune checkpoint inhibitors in Asia. Pág. 408-414.